Title: 
Official Title: To amend title 38, United States Code, to ensure that the Secretary of Veterans Affairs furnishes certain non-opioid pain medications to veterans, and for other purposes.
Number of Sections: 2
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Short titleThis Act may be cited as the NOPAIN for Veterans Act.

Section 2:
2.Inclusion of certain non-opioid pain medications in the National Formulary of the Department of Veterans Affairs (a)In generalSection 8125 of title 38, United States Code, is amended—
(1)in subsection (d), by adding at the end the following new paragraph:  (4)The term non-opioid pain management drug or biological product means a drug or biological product approved, granted, or cleared by the Food and Drug Administration to reduce postoperative pain, or to produce postsurgical or regional analgesia, without acting upon the body’s opioid receptors..
(2)by redesignating subsection (d), as so amended, as subsection (e); and (3)by inserting, after subsection (c), the following new subsection (d):

(d)The Secretary shall— (1)not later than one year after the date on which a non-opioid pain management drug or biological product becomes eligible for temporary additional payment under section 1833(t)(16)(G) of the Social Security Act (42 U.S.C. 1395l(t)(16)(G)), or eligible for separate payment under section 416.174 of title 42, Code of Federal Regulations (or successor regulation), include such non-opioid pain management drug or biological product in the national formulary of the Department; and
(2)include a non-opioid pain management drug or biological product in the drug standardization list of the Department.. (b)LimitationNone of the funds in the Cost of War Toxic Exposures Fund under section 324 of title 38, United States Code, may be used to carry out the amendments made by this section.
(c)ImplementationNot later than 90 days after the date of the enactment of this Act, the Secretary of Veterans Affairs shall implement the amendments made by this section.


================================================================================

Raw Text:
119 HR 4509 IH: NOPAIN for Veterans Act
U.S. House of Representatives
2025-07-17
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I119th CONGRESS1st SessionH. R. 4509IN THE HOUSE OF REPRESENTATIVESJuly 17, 2025Mr. Landsman (for himself, Mr. Van Orden, Mr. Pappas, Mr. Bergman, Ms. Sewell, and Mr. Hamadeh of Arizona) introduced the following bill; which was referred to the Committee on Veterans' AffairsA BILLTo amend title 38, United States Code, to ensure that the Secretary of Veterans Affairs furnishes certain non-opioid pain medications to veterans, and for other purposes. 
1.Short titleThis Act may be cited as the NOPAIN for Veterans Act. 2.Inclusion of certain non-opioid pain medications in the National Formulary of the Department of Veterans Affairs (a)In generalSection 8125 of title 38, United States Code, is amended—
(1)in subsection (d), by adding at the end the following new paragraph:  (4)The term non-opioid pain management drug or biological product means a drug or biological product approved, granted, or cleared by the Food and Drug Administration to reduce postoperative pain, or to produce postsurgical or regional analgesia, without acting upon the body’s opioid receptors..
(2)by redesignating subsection (d), as so amended, as subsection (e); and (3)by inserting, after subsection (c), the following new subsection (d):

(d)The Secretary shall— (1)not later than one year after the date on which a non-opioid pain management drug or biological product becomes eligible for temporary additional payment under section 1833(t)(16)(G) of the Social Security Act (42 U.S.C. 1395l(t)(16)(G)), or eligible for separate payment under section 416.174 of title 42, Code of Federal Regulations (or successor regulation), include such non-opioid pain management drug or biological product in the national formulary of the Department; and
(2)include a non-opioid pain management drug or biological product in the drug standardization list of the Department.. (b)LimitationNone of the funds in the Cost of War Toxic Exposures Fund under section 324 of title 38, United States Code, may be used to carry out the amendments made by this section.
(c)ImplementationNot later than 90 days after the date of the enactment of this Act, the Secretary of Veterans Affairs shall implement the amendments made by this section.